Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.

Adjuvant chemotherapy, cardiac disease history predict PCE after radiation for NSCLC

10 Sep 2017
Lack of public awareness about the way lung cancer strikes is a big factor in delaying diagnosis and treatment

Pericardial effusion (PCE) is a common adverse side effect following thoracic radiation therapy (RT) for locally-advanced nonsmall cell lung cancer (NSCLC), a new study reveals. Additionally, PCE risk is increased by adjuvant chemotherapy.

The effects of intensity-modulated radiation therapy (IMRT) vs passive scattering proton beam therapy for locally advanced, inoperable NSCLC were assessed in 201 patients (56.2 percent male). Those with chest irradiation or PCE prior to treatment were excluded.

The primary study endpoint was development of PCE. Other outcomes included time to development – calculated from the start of RT – and overall survival (OS). Univariate and Multivariate Cox proportional hazards analyses were used to determine hazard ratios (HR) for PCE development.

Over a median follow-up of 23.9 months, participants received a median RT dose of 74 Gy and heart dose of 12.2 Gy. PCE was reported in 42.8 percent (n=86) of the patients, of which 40.3 percent (n=81) had grade 2 and 5.2 percent (n=5) had grade 3 PCE.

The 1- and 2-year cumulative PCE incidence rates were 31.4 and 45.4 percent, respectively, with a median time to development of 8.9 months.

The OS at 2 years was significantly higher in the PCE group than in those without PCE (69.0 vs 44.3 percent; p=0.012); at 5 years, the difference in corresponding OS rates decreased (43.3 vs 25.6 percent).

In multivariate analysis, heart volume receiving 35 Gy >10 percent (HR, 2.14; p=0.002), adjuvant chemotherapy (HR, 2.82; p<0.001) and history of cardiac disease (HR, 1.68; p=0.020) were all independent risk predictors for PCE.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.